Trial NCT03717012

View at ClinicalTrials.gov 
Org. Study IDs: 1199-0324

Last trial update was posted on 2021-06-09

MeSH Interventions

Nintedanib

MeSH Conditions

Fibrosis Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis

Other Conditions


Stopping Reasons

The trial was terminated prematurely due to difficulties with recruitment because of the COVID-19 pandemic.

Limitations And Caveats

Trial was terminated prematurely due to difficulties with recruitment and a global BI recruitment hold implemented on 17 March 2020 because of the COVID-19 pandemic. The recruitment rate was slow and the target number of participants to be recruited was not reached. No inferential statistical analysis was performed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID